Article
Precision Oncology in Sarcomas: Divide and Conquer
25 Apr 2019
Abstract excerpt
Sarcomas are a heterogeneous group of rare malignancies that exhibit remarkable heterogeneity, with more than 50 subtypes recognized. Advances in next-generation sequencing technology have resulted in the discovery of genetic events in these mesenchymal tumors, which in addition to enhancing understanding of the biology, have opened up avenues for molecularly targeted therapy and immunotherapy. This review...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
